Feasibility and Safety of NeuroFlo in Stroke Patients Receiving Tissue Plasminogen Activator
Feasibility and Safety of NeuroFlo in Stroke Patients Receiving Tissue Plasminogen Activator
To assess the safety and feasibility of using the NeuroFlo catheter to treat acute ischemic
 stroke patients following administration of intravenous tPA.
Inclusion Criteria:

 -  Ischemic stroke

 -  NIHSS between 5-22

 -  Persistent clinical deficits following administration of rt-PA

 Exclusion Criteria:

 -  Planned thrombectomy

 -  Aortic pathology

 -  Severe heart disease

 -  Other conditions the doctor will assess